
Lantern Pharma Inc.
NASDAQ:LTRN

Intrinsic Value
The intrinsic value of one
LTRN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.8 USD,
Lantern Pharma Inc.
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Lantern Pharma Inc.
Fundamental Analysis


Revenue & Expenses Breakdown
Lantern Pharma Inc.
Balance Sheet Decomposition
Lantern Pharma Inc.
Current Assets | 29.9m |
Cash & Short-Term Investments | 28.1m |
Other Current Assets | 1.9m |
Non-Current Assets | 372.3k |
PP&E | 335.6k |
Other Non-Current Assets | 36.7k |
Free Cash Flow Analysis
Lantern Pharma Inc.
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Lantern Pharma Inc.
Revenue
|
0
USD
|
Operating Expenses
|
-21.2m
USD
|
Operating Income
|
-21.2m
USD
|
Other Expenses
|
2.1m
USD
|
Net Income
|
-19.1m
USD
|
LTRN Profitability Score
Profitability Due Diligence
Lantern Pharma Inc.'s profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Lantern Pharma Inc.'s profitability score is hidden . The higher the profitability score, the more profitable the company is.
LTRN Solvency Score
Solvency Due Diligence
Lantern Pharma Inc.'s solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Lantern Pharma Inc.'s solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LTRN Price Targets Summary
Lantern Pharma Inc.
According to Wall Street analysts, the average 1-year price target for
LTRN
is 22.44 USD
with a low forecast of 18.18 USD and a high forecast of 27.3 USD.
Dividends
Current shareholder yield for LTRN is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
LTRN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.8 USD,
Lantern Pharma Inc.
is
hidden
.